Objective − To report a rare case of Idiopathic Juvenile Osteoporosis (IJO) presenting as kyphosis and loss of height. Case presentation − A 9-year-old girl presented with a 6-month history of progressive loss of height, increasing roundness of the shoulders and atraumatic mild thoracolumbar discomfort. A diagnosis of IJO was subsequently made. In the course of treatment, bisphosphonates were commenced and multiple procedures were required to address lower limb fractures and angular deformities. At 10 years follow-up at skeletal maturity and after pamidronate therapy, spontaneous resolution of spinal deformity was observed resulting in a normal range of daily and sporting activities. Conclusion − IJO is a rare condition that should be considered in paediatric patients presenting with unexplained progressive loss of height and an increasing kyphosis where other causes have been excluded.
Introduction
Idiopathic Juvenile Osteoporosis (IJO) is a rare sporadic condition characterised by low bone mass that affects the pre-pubertal paediatric population, usually between 8 and 14 years (1, 2) . The manifestations of this disease include bone pain, dental abnormalities, short stature and skeletal fractures with subsequent deformities (3, 4) . Although osteoporosis resolves at skeletal maturity, the deformities that develop during the acute phase of the condition affecting the spine and appendicular skeleton can have profound effects and produce long-term disability if not recognised and treated early. The clinical presentation of IJO has wide variation, thus making diagnosis challenging. We report a patient with IJO presenting primarily as progressive loss of trunk height in an otherwise healthy 9-year-old girl.
Case Presentation
A 9-year-old girl presented to clinic following referral from primary care with a 6-month history of progressive loss of height, increasing roundness of the shoulders and atraumatic mild thoracolumbar discomfort on playing sport, which was relieved by rest. The family's main concern for presentation to the General Practitioner was that they had noticed their daughter to be losing height over the preceding 6 months. The patient was otherwise fit and well without significant medical, perinatal or family history.
On examination, the patient was 136.5 cm tall with sitting height 69.5 cm and weight 32.1 kg ( Table 1) . The patient had an increased smooth thoracic kyphosis that was non-tender on palpation. Range of motion of the spine was full and pain free. There were no cutaneous abnormalities overlying the spine and no neurological abnormalities were identified. The patient's shoulders and pelvis were symmetrical and there was no leg length inequality. Her gait was normal throughout each phase of the gait cycle.
Haematological and biochemical parameters including serum calcium, phosphate, alkaline phosphatase, thyroid and parathyroid hormones were within normal limits. The only biochemical abnormality detected was low 25-OH Vitamin-D of 5 nmol/L (normal range: 25-170 nmol/L). On radiographic assessment of the spine, spontaneous anterior wedge compression fractures extending from T4-T11 and across L1/L2 were noted. The vertebral endplates were biconcave with reciprocal increase in intervertebral body space. The vertebral bodies appeared osteopenic. Thoracic kyphosis and lumbar lordosis measured 60 0 and 75 0 respectively with negative global sagittal balance of the spine measuring -2.5 cm at presentation (Fig. 1a) . Further investigations were performed which included a bone marrow aspirate and bone trephine which showed no abnormalities. A Dual Energy X-ray Absorptiometry (DEXA) scan was undertaken which showed the bone mineral density (BMD) of the spine to be 0.301 and a Z-score of -4.1 (Table 1) , figures indicative of osteoporosis. In the absence of any other attributable cause, the diagnosis of IJO was made. The patient was commenced on bisphosphonate therapy (Pamidronate 1 mg/kg a month for 12 months followed by half dose for additional 6 months). Calcium and Vitamin-D supplementation was also provided. One year following diagnosis, the BMD of the spine had increased by 82.8% and the Z score was -1.2 (Table 1) . Repeat spinal radiographs showed improvement in the appearance of the affected vertebral bodies with gradual reconstitution of anterior vertebral height in addition to cyclical Pamidronate 'metaphyseal lines' (Fig. 1b) . Thoracic kyphosis improved from 60 0 to 30 0 and the patient's sitting height increased by 6 cm.
Unfortunately, the patient went onto sustain a number of appendicular skeletal fractures, each of which were sustained during normal everyday activities (Table 2) . Ten months following diagnosis, she complained of atraumatic bilateral proximal tibial pain that was worse on exercise. Clinical examination revealed no obvious deformity or abnormality except for pain on palpation around the proximal tibial metaphyseal regions bilaterally. Radiographs showed proximal tibial metaphyseal stress fractures, which were treated conservatively for 12 months with activity modifi cation and cessation of Pamidronate treatment in the latter 6 months to encourage union. Subsequent bilateral anterior epiphysiodesis was undertaken to address bilateral posterior slope deformity (35 0 on the left and 30 0 on the right) using a single 4 mm partially threaded cancellous screw (Fig.  2a ). An improvement of 15 0 was achieved bilaterally prior to physeal closure (Fig. 2b) . A multidisciplinary team decision was made 
Fig. 1. Lateral Spinal Radiographs Taken at: A) Presentation Showing Compression Fractures of T4-T11 And L1/L2 Resulting in Increased Kyphosis Of 60 0 ; B) 1 Year Post-Presentation Showing Improvement to 30 0 of Kyphosis And Cyclical Pamidronate Metaphyseal Lines; C) 7 Years Post-Presentation with Maintenance of Th oracic Kyphosis and Normal Global Sagittal Balance of the Spine (Arrows Indicate Stress Fractures).
A B C not to restart Pamidronate at this time due to signifi cant improvement in BMD and Zscores on DEXA scan. However, due to a subsequent left distal femoral fracture at age 11 years treated with external fi xation, Pamidronate was recommenced at a dose of 1mg/kg for 2 days every 2 months for 1 year followed by 1mg/kg for 2 days every 4 months continued. Despite this, the patient complained of right hip discomfort only 2 months following removal of her left femoral external fi xator. Radiographs showed a right femoral neck stress fracture requiring operative treatment, which included a Pauwell's valgus osteotomy (Fig. 3) . Four years later, the patient described similar discomfort in her left hip. Radiological investigations including MRI scanning indicated a left trans-cervical femoral neck stress fracture. Cannulated screw fi xation of the left hip was subsequently undertaken at age 15 years.
Two years following her left hip fi xation, the patient again started complaining of left hip pain. Radiographs revealed a subtrochanteric stress fracture. Th is necessitated removal of the cannulated screws and insertion of a cepho-medullary nail. Th e fracture subsequently went onto union. (Fig. 1c) . Lumbar lordosis had improved from initial 75 o to 50 o and global sagittal balance from initial -2.5cm to -0.8cm. Furthermore, Vitamin D levels had returned to within normal limits. On clinical examination, there was no cosmetic deformity and the spine was well-balanced with normal range of pain free movement. Pamidronate therapy was stopped.
Ten years following diagnosis, the patient is leading an active lifestyle, regularly cycling and swimming. However, higher level sporting activity is restricted by the onset of lumbar discomfort which is managed conservatively. With regards to her spine, hips and knees, she maintains a full range of pain free movement at rest. Radiographs show the femoral osteotomy to have united and there is no current evidence of implant loosening, fatigue or avascular necrosis of the femoral heads. She has achieved a functional outcome and has been discharged from routine clinical care.
Discussion
IJO can produce signifi cant patient morbidity at a stage of rapid skeletal growth and high level of activities. Th ere is a paucity of information within the current literature limited to approximately 100 case reports (2, 3). Th is rare masquerading condition presents a diagnostic conundrum for physicians and surgeons.
IJO is a condition aff ecting primary bone mineralisation characterised by reduced bone mass and structural integrity, as well as increased risk of fractures (5, 6, 7) . It is a diagnosis of exclusion when other primary and
Fig. 3. AP Radiograph of the Right Hip Showing. A) an Intra-Capsular Stress Fracture of the Right Femoral Neck B) Union Following Operative Fixation with Pauwell's Valgus Osteotomy (Arrows Indicate Stress Fracture).
A B secondary causes of osteoporosis (BMD <-2 standard deviations/Z score of -2 or below) have been fully investigated and excluded (4, 7, 8) . The list of differential diagnoses is extensive but each must be carefully considered. Primary causes of bone demineralisation include osteogenesis imperfecta, which results in a structural defect in Type I collagen. Osteogenesis imperfecta type I, II and III may be easily differentiated by the absence of scleral involvement, hearing deficits and their severe progressive nature. Type IV and the newer types V, VI and VII can be excluded as it was in this case by the absence of family history due to the autosomal dominant pattern of inheritance (9, 10). There has been so far no conclusive evidence of inheritable genetic mutations associated with IJO (11) . Secondary causes of bone demineralisation include rickets, which is characterised by abnormal values of alkaline phosphatase, phosphate, serum calcium and pathognomonic radiological changes. Although our patient had a low Vitamin D level, each of the other biochemical parameters which could suggest rickets were within normal limits. Metabolic causes of osteoporosis require investigations and are associated with abnormal levels of serum urea, creatinine, urine pH and blood gases. Endocrinopathies necessitate hormonal assays and Wilson's disease is characteristically identified by abnormal ceruloplasmin and copper values (3, 8) .
Clinical presentation along with biochemical, histopathological and radiological investigations substantiated the diagnosis of IJO in our patient. The most frequently described presenting features of IJO are inability to mobilise, multiple appendicular skeletal fractures and back pain, the latter being a mild presenting feature in our patient (12) . However, it was the progressive loss of trunk height prior to any long bone fractures that was the trigger for referral in our patient. The natural course of IJO is self-limiting with remission occurring after puberty. Current treatment includes activity modification to limit the occurrence of fragility fractures during the active phase of skeletal growth. In addition, recognised medical therapies include bisphosphonate treatment, calcium and Vitamin -D supplementation to assist bone formation and mineralisation; all these therapies were used in the case described (3).
Conclusion
The presentation of loss of trunk height combined with increased kyphosis and pain in an otherwise healthy child should raise clinical suspicion of a disorder of bone demineralisation with IJO featuring as a differential diagnosis.
Learning Points:
• Idiopathic Juvenile Osteoporosis (IJO) is a rare 'diagnosis of exclusion' affecting primary bone mineralisation.
• IJO should be considered in paediatric patients presenting with loss of trunk height, kyphosis and fragility fractures.
• Early diagnosis and treatment aims to prevent further fractures and subsequent skeletal deformity. • Bisphosphonate treatment has been shown to enhance vertebral body height recovery with subsequent improvement in thoracic kyphosis and global sagittal balance of the spine.
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